In its new drug application, Stealth BioTherapeutics described elamipretide as a first-in-class mitochondrial protective ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

While poppy seeds are often an ingredient in baked goods and pastries, they also -- depending on how they are harvested and ...

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...

Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, persistent shortages prevail.

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

Amazon (NASDAQ:AMZN) announced on Wednesday that its pharmacy business plans to open pharmacies in 20 new cities across the U ...

The U.S. health regulator has declined to approve Zealand Pharma's drug to prevent and treat low blood sugar in children with ...

Thomas Kingston, a relative of Prince William and Prince Harr y, had recently been prescribed new medication before he was ...

The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...